Skip to main
ASPI

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes Inc has demonstrated significant revenue growth, with reported revenues of approximately $4.9 million, reflecting an annual increase of about 345.5% from the previous year's $1.1 million and a sequential rise of 308.3% from $1.2 million in the prior quarter. The company’s successful application of laser-based quantum enrichment technology to ytterbium-176 has validated its processes and indicates the potential for similar advancements in enriching uranium-235, thereby positioning ASP to capitalize on the expanding advanced nuclear fuel market. Furthermore, rising global helium demand and strategic opportunities within the LEU+ and HALEU markets suggest that ASP Isotopes could see significantly higher revenue streams, supporting a positive outlook for the company's financial trajectory.

Bears say

ASP Isotopes Inc. reported a gross margin of approximately 8.7%, significantly below the estimated 62.4% and down from both the prior year's 27.0% and the previous quarter's 47.7%, indicating serious operational inefficiencies. The company experienced a net loss of $12.1 million in Q3 2025, a deterioration compared to the net loss of $7.3 million in Q3 2024, underscoring the financial strain amidst revenue delays linked to postponed production of key isotopes. Furthermore, challenges such as diminished liquidity, increased interest rates, and ongoing volatility in global credit markets contribute to a negative financial outlook, exacerbated by management's expectations of further shipment delays for critical products like silicon-28.

ASPI has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Buy based on their latest research and market trends.

According to 2 analysts, ASPI has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.